misleading statements

Class action filed against $UGXY alleging misleading statements about Phase III Orbit study for rare bone disease treatment. Investors may recover losses from August 2023 forward.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facilities between January and November 2025. Investors can seek lead plaintiff status by April 3, 2026.

Class action filed against Aldeyra Therapeutics alleging false reproxalap trial data claims; investors from Nov 2023-Mar 2026 may be eligible.

Schall Law Firm launches class action against Power Solutions International for allegedly misrepresenting data center market prospects and manufacturing costs between May 2025 and March 2026.

Robbins LLP files class action against $ATRA over undisclosed manufacturing issues tied to FDA rejection of lead drug tabelecleucel, citing 57% stock plunge.

Robbins LLP filed a class action lawsuit against $PSIX after stock collapsed 29% on weak margin guidance, alleging investor deception about data center demand and manufacturing efficiency.

Robbins LLP sued Hercules Capital for allegedly overstating due diligence and misclassifying portfolio investments, triggering a 7.9% stock decline following damaging media report.

Hagens Berman files class action against $CORT over alleged concealment of FDA warnings. Stock plunged 50% after December rejection, erasing $2.5B in market value.

Apollo Global Management sued over alleged false statements regarding Jeffrey Epstein relationship. Stock plunged 15%, wiping $12B in market cap following investigative revelations.

Coty faces securities lawsuit after revealing sharp operating income declines weeks after reassuring investors. CEO departure and withdrawn guidance triggered 8%+ stock drop.

PayPal faces securities class action lawsuit following CEO exit and $10 billion shareholder loss after withdrawing 2027 guidance, alleging management misled investors on key metrics.

Boston Scientific faces securities class action alleging false statements about Electrophysiology segment growth. Lead plaintiff deadline: May 4, 2026.

Plug Power faces class action lawsuit deadline this Friday over alleged misstatements about DOE loan program and hydrogen strategy during 2025.

Class action lawsuit filed against Gemini Space Station ($GEMI) alleges securities fraud tied to September 2025 IPO. Stock has collapsed 78.7% to $5.96 from $28 launch price.

Class action lawsuit filed against $MNDY for allegedly misrepresenting financial performance. Stock plunged 33% after company withdrew $1.8B revenue target.

Portnoy Law Firm sues Ultragenyx on behalf of investors over alleged misstatements regarding Phase III Orbit study methodology and efficacy claims for setrusumab.

Rosen Law Firm filed a securities class action against Aldeyra Therapeutics for alleged false statements. Affected investors must act by May 29, 2026 to become lead plaintiffs.

Rosen Law Firm encourages Power Solutions International investors to join securities class action before lead plaintiff deadlines. Allegations include overstated sales capabilities and understated manufacturing costs.

Alight faces class action over allegedly misleading statements about growth. Company missed targets, cut guidance, lost CEO/CFO, and eliminated dividend.

Class action lawsuit filed against $VITL for allegedly making false statements about ERP system risks and downplaying delays that caused missed earnings targets.